Aclaris Therapeutics, Inc. (ACRS)

Aclaris Therapeutics Revenue

Aclaris Therapeutics had revenue of $2.00M in the quarter ending March 31, 2026, with 37.18% growth. This brings the company's revenue in the last twelve months to $8.37M, down -52.94% year-over-year. In the year 2025, Aclaris Therapeutics had annual revenue of $7.83M, down -58.19%.

• Revenue (ttm): $8.37M
• Revenue Growth: -52.94%
• P/S Ratio: 89.14
• Revenue / Employee: $114,616
• Employees: 73
• Market Cap: 745.80M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.83M	-10.89M	-58.19%
Dec 31, 2024	18.72M	-12.53M	-40.09%
Dec 31, 2023	31.25M	1.50M	5.03%
Dec 31, 2022	29.75M	22.99M	340.05%
Dec 31, 2021	6.76M	279.00K	4.30%
Dec 31, 2020	6.48M	2.26M	53.35%
Dec 31, 2019	4.23M	-1.92M	-31.28%
Dec 31, 2018	6.15M	4.47M	265.48%
Dec 31, 2017	1.68M	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error